Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Saida T, Itoyama Y, Tashiro K, Kira J-I, Hao Q, the Interferon Beta-1a Multiple Sclerosis Study Group of Japan